Bdenza 40 mg Capsule

Brand Name:   Bdenza
Molecule:   Enzalutamide
Strength:   40 mg
Quantity:   112 Capsules
Form:   Capsule
Packaging Type:   Strips
Manufacturer/Marketed By:   BDR Pharma
Country of Origin:   India

Description

Bdenza 40 mg Capsule contains Enzalutamide 40 mg, an advanced anti-cancer medication primarily used in the treatment of prostate cancer. It belongs to a class of medicines known as androgen receptor inhibitors, which work by blocking the effects of male hormones (androgens) that help prostate cancer cells grow and spread.

Bdenza is prescribed by oncologists for patients with advanced, metastatic, or castration-resistant prostate cancer and has become an important treatment option for improving survival outcomes and delaying disease progression.

At MedsMonk, we strive to provide genuine oncology medicines sourced from trusted pharmaceutical manufacturers while ensuring safe and reliable delivery.

Related Products

Related Posts:

Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies

The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another

READ MORE »
Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma

n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026.n n This marks an important

READ MORE »
FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors

n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026.n n Brain tumors, especially high-grade

READ MORE »
0 reviews
0
0
0
0
0

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.